You Can’t Learn Much From One COVID-19 Patient — Even When That Patient Is President Trump
Oct. 8 marked a major milestone in what we know about the efficacy of remdesivir, the experimental antiviral medication that was the first therapy drug to be issued an emergency use authorization for COVID-19 in the United States. On that… Continue Reading